BR0312145A - Proteìna, polinucleotìdeo isolado, vetor recombinante, célula, composição adjuvante, composição de vacina, uso de uma proteìna, e, composição farmacêutica - Google Patents

Proteìna, polinucleotìdeo isolado, vetor recombinante, célula, composição adjuvante, composição de vacina, uso de uma proteìna, e, composição farmacêutica

Info

Publication number
BR0312145A
BR0312145A BR0312145-3A BR0312145A BR0312145A BR 0312145 A BR0312145 A BR 0312145A BR 0312145 A BR0312145 A BR 0312145A BR 0312145 A BR0312145 A BR 0312145A
Authority
BR
Brazil
Prior art keywords
protein
composition
cell
recombinant vector
isolated polynucleotide
Prior art date
Application number
BR0312145-3A
Other languages
English (en)
Inventor
Wilhelmus Gerardus Johan Degen
Virgil Elisabeth Josep Schijns
Joan Burnside
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0312145A publication Critical patent/BR0312145A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Catching Or Destruction (AREA)

Abstract

"PROTEìNA, POLINUCLEOTìDEO ISOLADO, VETOR RECOMBINANTE, CéLULA, COMPOSIçãO ADJUVANTE, COMPOSIçãO DE VACINA, USO DE UMA PROTEìNA, E, COMPOSIçãO FARMACêUTICA". A invenção fornece novas citocinas aviárias que compreendem uma subunidade de polipeptídeo p40, tal como Chicken IL 12. Também são apresentados ácidos nucléicos que codificam tais polipeptídeos, bem como adjuvantes e vacinas que compreendem as citocinas ou polipeptídeos da invenção.
BR0312145-3A 2002-06-26 2003-06-25 Proteìna, polinucleotìdeo isolado, vetor recombinante, célula, composição adjuvante, composição de vacina, uso de uma proteìna, e, composição farmacêutica BR0312145A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39166202P 2002-06-26 2002-06-26
US10/464,630 US7347996B1 (en) 2002-06-26 2003-06-17 Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines
PCT/EP2003/006832 WO2004003017A1 (en) 2002-06-26 2003-06-25 Avian cytokines, such il-12, comprising a p40 and/or p35 subunit(s)

Publications (1)

Publication Number Publication Date
BR0312145A true BR0312145A (pt) 2005-04-05

Family

ID=30003199

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312145-3A BR0312145A (pt) 2002-06-26 2003-06-25 Proteìna, polinucleotìdeo isolado, vetor recombinante, célula, composição adjuvante, composição de vacina, uso de uma proteìna, e, composição farmacêutica

Country Status (11)

Country Link
US (1) US7347996B1 (pt)
EP (1) EP1519953B1 (pt)
JP (1) JP4376783B2 (pt)
AT (1) ATE418564T1 (pt)
AU (1) AU2003249893B2 (pt)
BR (1) BR0312145A (pt)
CA (1) CA2490885A1 (pt)
DE (1) DE60325477D1 (pt)
ES (1) ES2318163T3 (pt)
MX (1) MXPA04012750A (pt)
WO (1) WO2004003017A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102056941A (zh) * 2008-06-23 2011-05-11 英特威国际有限公司 编码白细胞介素-12的重组火鸡疱疹病毒
GB201214974D0 (en) * 2012-08-22 2012-10-03 Univ Edinburgh Avian proteins, nucleic acids and uses thereof
CN108424916B (zh) * 2018-03-29 2021-04-30 中国水产科学研究院南海水产研究所 花鲈白细胞介素IL-12p40基因及其用途
WO2022152939A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997013859A1 (en) 1995-10-11 1997-04-17 Brigham And Women's Hospital, Inc. A novel haematopoietic cytokine and uses therefor
US20030129161A1 (en) 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant

Also Published As

Publication number Publication date
ATE418564T1 (de) 2009-01-15
ES2318163T3 (es) 2009-05-01
DE60325477D1 (de) 2009-02-05
CA2490885A1 (en) 2004-01-08
MXPA04012750A (es) 2005-03-23
US7347996B1 (en) 2008-03-25
AU2003249893A1 (en) 2004-01-19
EP1519953A1 (en) 2005-04-06
EP1519953B1 (en) 2008-12-24
US20080063623A1 (en) 2008-03-13
AU2003249893B2 (en) 2009-09-03
JP4376783B2 (ja) 2009-12-02
JP2006507805A (ja) 2006-03-09
WO2004003017A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
BRPI0512286A (pt) proteìnas quiméricas inibidoras da angiogênese e o uso
ATE491471T1 (de) Adjuvantien für dns impstoffe basierend auf imidazochinoline
BRPI0412799A (pt) imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
DK0851927T3 (da) Forbindelser til immunterapi og diagnosticering af tuberkulose
DE69838334D1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE184052T1 (de) Gdf-1 und uog1 proteine
ATE292685T1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
AR008727A1 (es) COMPOSICIONES Y PROTEINAS DE FUSIoN QUE COMPRENDEN UN POLIPEPTIDO QUE COMPRENDE UNA PORCION INMUNOGENICA DE UNA PROTEINA DE PROSTATA O SU VARIANTE, Y USOS DE LAS MISMAS PARA PREPARAR UN MEDICAMENTO
PT737207E (pt) Inibidores de plasmina humana derivados de dominios kunitz
BRPI0519705A2 (pt) composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo
DE69130262D1 (de) Isolierte virale proteine als cytokinantagonisten
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
GB9219936D0 (en) Vaccines
DK0851926T3 (da) Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
BR0312889A (pt) Polipeptìdeo t20 peguilado
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
DK0791063T3 (da) Bærerprotein med adjuvansvirkning, immunogent kompleks omfattende det, fremgangsmåde til fremstilling deraf, nukleotidsekvens og vaccine
BR0312145A (pt) Proteìna, polinucleotìdeo isolado, vetor recombinante, célula, composição adjuvante, composição de vacina, uso de uma proteìna, e, composição farmacêutica
DK0484382T3 (da) Felint calicivirus-capsid-protein og nucleotidsekvens
DE60118359D1 (de) Humanische pellino-polypeptide
BR112022026248A2 (pt) Conjugados de citocinas
DK0815233T3 (da) Nye aviære cytokiner og genetiske sekvenser, der koder derfor

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: INTERVET INTERNATIONAL B.V. (NL)

Free format text: TRANSFERIDO DE: AKZO NOBEL N.V.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2261 DE 06/05/2014.